AIM: To identify molecular markers shared across South African esophageal squamous cell carcinoma (ESCC) cell lines using cytogenetics, fluorescence in situ hybridization (FISH) and single nucleotide polymorphism (SNP) array copy number analysis. METHODS: We used conventional cytogenetics, FISH, and multicolor FISH to characterize the chromosomal rearrangements of five ESCC cell lines established in South Africa. The whole genome copy number profile was established from 250K SNP arrays, and data was analyzed with the CNAT 4.0 and GISTIC software. RESULTS: We detected common translocation breakpoints involving chromosomes 1p11-12 and 3p11.2, the latter correlated with the deletion, or interruption of the EPHA3 gene. The most significant amplifications involved the following chromosomal regions and genes: 11q13.3 (CCND1, FGF3, FGF4, FGF19, MYEOV), 8q24.21(C-MYC, FAM84B), 11q22.1-q22.3 (BIRC2, BIRC3), 5p15.2 (CTNND2), 3q11.2-q12.2 (MINA) and 18p11.32 (TYMS, YES1). The significant deletions included 1p31.2-p31.1 (CTH, GADD45α, DIRAS3), 2q22.1 (LRP1B), 3p12.1-p14.2 (FHIT), 4q22.1-q32.1 (CASP6, SMAD1), 8p23.2-q11.1 (BNIP3L) and 18q21.1-q21.2 (SMAD4, DCC). The 3p11.2 translocation breakpoint was shared across four cell lines, supporting a role for genes involved at this site, in particular, the EPHA3 gene which has previously been reported to be deleted in ESCC. CONCLUSION: The finding that a significant number of genes that were amplified (FGF3, FGF4, FGF19, CCND1 and C-MYC) or deleted (SFRP2 gene) are involved in the Wnt and fibroblast growth factor signaling pathways, suggests that these pathways may be activated in these cell lines.
AIM: To identify molecular markers shared across South African esophageal squamous cell carcinoma (ESCC) cell lines using cytogenetics, fluorescence in situ hybridization (FISH) and single nucleotide polymorphism (SNP) array copy number analysis. METHODS: We used conventional cytogenetics, FISH, and multicolor FISH to characterize the chromosomal rearrangements of five ESCC cell lines established in South Africa. The whole genome copy number profile was established from 250K SNP arrays, and data was analyzed with the CNAT 4.0 and GISTIC software. RESULTS: We detected common translocation breakpoints involving chromosomes 1p11-12 and 3p11.2, the latter correlated with the deletion, or interruption of the EPHA3 gene. The most significant amplifications involved the following chromosomal regions and genes: 11q13.3 (CCND1, FGF3, FGF4, FGF19, MYEOV), 8q24.21(C-MYC, FAM84B), 11q22.1-q22.3 (BIRC2, BIRC3), 5p15.2 (CTNND2), 3q11.2-q12.2 (MINA) and 18p11.32 (TYMS, YES1). The significant deletions included 1p31.2-p31.1 (CTH, GADD45α, DIRAS3), 2q22.1 (LRP1B), 3p12.1-p14.2 (FHIT), 4q22.1-q32.1 (CASP6, SMAD1), 8p23.2-q11.1 (BNIP3L) and 18q21.1-q21.2 (SMAD4, DCC). The 3p11.2 translocation breakpoint was shared across four cell lines, supporting a role for genes involved at this site, in particular, the EPHA3 gene which has previously been reported to be deleted in ESCC. CONCLUSION: The finding that a significant number of genes that were amplified (FGF3, FGF4, FGF19, CCND1 and C-MYC) or deleted (SFRP2 gene) are involved in the Wnt and fibroblast growth factor signaling pathways, suggests that these pathways may be activated in these cell lines.
Entities:
Keywords:
Cancer; Esophagus; Fluorescent in situ hybridization; Single nucleotide polymorphism arrays
Authors: Yuesheng Jin; Charlotte Jin; Simon Law; Kent-Man Chu; Hao Zhang; Bodil Strombeck; Anthony P W Yuen; Yok-Lam Kwong Journal: Cancer Genet Cytogenet Date: 2004-01-01
Authors: Jianming Ying; Hongyu Li; Paul Murray; Zifen Gao; Yun-Wen Chen; Yajun Wang; Kwan Yeung Lee; Anthony T C Chan; Richard F Ambinder; Gopesh Srivastava; Qian Tao Journal: Epigenetics Date: 2007-01-15 Impact factor: 4.528
Authors: J W Janssen; J W Vaandrager; T Heuser; A Jauch; P M Kluin; E Geelen; P L Bergsagel; W M Kuehl; H G Drexler; T Otsuki; C R Bartram; E Schuuring Journal: Blood Date: 2000-04-15 Impact factor: 22.113
Authors: Sivan M Bokobza; Lin Ye; Howard E Kynaston; Robert E Mansel; Wen G Jiang Journal: Cancer Genomics Proteomics Date: 2009 Mar-Apr Impact factor: 4.069
Authors: Johannes W G Janssen; Marguerite Cuny; Béatrice Orsetti; Carmen Rodriguez; Hélène Vallés; Claus R Bartram; Ed Schuuring; Charles Theillet Journal: Int J Cancer Date: 2002-12-20 Impact factor: 7.396
Authors: L Burkhardt; T J Grob; I Hermann; E Burandt; M Choschzick; F Jänicke; V Müller; C Bokemeyer; R Simon; G Sauter; W Wilczak; A Lebeau Journal: Breast Cancer Res Treat Date: 2009-12-22 Impact factor: 4.872
Authors: P Hofman; C Butori; K Havet; V Hofman; E Selva; N Guevara; J Santini; E Van Obberghen-Schilling Journal: Br J Cancer Date: 2008-02-12 Impact factor: 7.640
Authors: Ilda P Ribeiro; Joana M Rodrigues; Alexandra Mascarenhas; Vanessa Marques; Francisco Caramelo; Maria J Julião; Thomas Liehr; Joana B Melo; Isabel M Carreira Journal: Genes Genomics Date: 2019-07-18 Impact factor: 1.839
Authors: Claire C Bommeljé; Víola B Weeda; Guochang Huang; Kushyup Shah; Sarina Bains; Elizabeth Buss; Manish Shaha; Mithat Gönen; Ronald Ghossein; Suresh Y Ramanathan; Bhuvanesh Singh Journal: Clin Cancer Res Date: 2013-11-05 Impact factor: 12.531